Business

GB Sciences' Dr. Andrea Small-Howard, Chief Science Officer, Will Be Moderating a Panel Discussion in "Cannabis Is Medicine" at the "State of Cannabis" Conference on the Queen Mary

GB Sciences' Dr. Andrea Small-Howard, Chief Science Officer, Will Be Moderating a Panel Discussion in "Cannabis Is Medicine" at the "State of Cannabis" Conference on the Queen Mary.

articleGb Sciences, Inc.September 18, 20184/company/gb-sciences-inc/news/gb-sciences-dr-andrea-small-howard-chief-science-officer-will-be-moderating-a-panel-discussion-in-cannabis-is-medicine-at-the-state-of-cannabis-conference-on-the-queen-mary
GB Sciences' Dr. Andrea Small-Howard, Chief Science Officer, Will Be Moderating a Panel Discussion in "Cannabis Is Medicine" at the "State of Cannabis" Conference on the Queen Mary

About this update from Gb Sciences, Inc.

[{"type":"text","content":"\n\n\n\nGB Sciences' Dr. Andrea Small-Howard, Chief Science Officer, Will Be Moderating a Panel Discussion in \"Cannabis Is Medicine\" at the \"State of Cannabis\" Conference on the Queen Mary\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nGB Sciences' Dr. Andrea Small-Howard, Chief Science Officer, Will Be Moderating a Panel Discussion in \"Cannabis Is Medicine\" at the \"State of Cannabis\" Conference on the Queen Mary\nPR Newswire\nLAS VEGAS, Sept. 18, 2018\n\n\n\nDr. Andrea Small-Howard is featured in the \"Meeting of the Minds\" at the two-day educational conference hosted on the historic Queen Mary. \n LAS VEGAS, Sept. 18, 2018 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announces that Dr. Andrea Small-Howard will be moderating the panel discussion which kicks-off the \"Cannabis Is Medicine Track\" and explores important Research Initiatives. Of great interest to this panel is The Medical Cannabis Research Act of 2018, which was unanimously approved by the House Judiciary Committee with widespread bipartisan support on September 13th. \n\n \n \n\n \nThis unprecedented legislation will expand the number of federal licenses granted for growing and studying cannabis by at least two new applicants; thus, ending the University of Mississippi's fifty-year reign as the sole source of cannabis for research in the US. This bill also contains a provision that will allow the Department of Veterans Affairs to conduct research on medical cannabis, which has been an area of great interest for panelist, Dr. Sue Sisley, a leading clinical expert in the treatment of posttraumatic stress disorder (PTSD). The other esteemed panelists joining Dr. Small-Howard, include Dr. Daniele Piomelli, pioneering endocannabinoid system researcher and Director of the Institute for the Study of Cannabis at the University of California, Irvine, and Dr. Mowgli Holmes, CEO & Chief Scientific Officer at Phylos Bioscience in Oregon. \n\"Most Americans and our government seem to agree that there is an urgent need for more research on the medical applications of cannabis and the potential for...

More updates from Gb Sciences, Inc.